Atlas Trials

Berberine Prevent Contrast-induced Nephropathy in Patients With Diabetes

Clinical trial NCT02808351 · COMPLETED

Trial details

NCT number
NCT02808351
Sponsor
Nanjing First Hospital, Nanjing Medical University
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Diabetes MellitusChronic Kidney Disease
Start date
2016-07-01
Primary completion
2021-12-01
Enrollment
800

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.